ArticleBMC cancer2011

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer.

Fotios Loupakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.